Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
21 November 2014
Header
Header image
From our blog

From our blog

Post G20 – India Seems Open for Business
21 November 2014 by Brendan Barnes

For the EU, struggling to find its own path to growth, decisions made in India matter, but it would be wrong to suggest that these are simple choices. Take the example of Intellectual Property in the pharmaceutical area. India has been an outlier in IP policy in international terms, both in terms of its law and its interpretation of the international rules. It has also faced backlogs in dealing with patent applications which have necessitated the recruitment of more examiners. 

Read more

From our blog

Implementing WHO’s Global Action Plan on Anti-Microbial Resistance
21 November 2014 by Brendan Barnes

On the occasion of European Antibiotic Awareness Day, 18 November, EFPIA’s Brendan Barnes writes on what it will take to successfully implement the WHO’s global action plan on anti-microbial resistance.

Read more

Events calendar

Events Calendar

“Development Pathways for Advanced Therapy Medicinal Products”
On 15/12/2014 (London, UK )

3rd Edition – A workshop organised by EBE in collaboration with European Medicines Agency and the Italian Embassy’s Scientific Office in London Chairs: Eduardo Bravo, EBE Vice President [...] Read more

What we are reading

What we are reading

Last-line drug resistance poses 'alarming' European health threat
21 November 2014 (EurActiv)

More and more infections in Europe are proving able to evade even the most powerful antibiotics, posing an alarming threat to patient safety in the region, health officials said on Monday (17 November).

Read more

What we are reading

European Antibiotic Awareness Day 2014: News release
21 November 2014 (ECDC)

On the occasion of the 7th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance (EARS-Net annual report and interactive database) and adaptable campaign materials targeting self-medication with antibiotics.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail